Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Randy912
    Junior Member
    • Aug 2016
    • 2

    RankProduct - Is this a valid analysis?

    Hello,

    I analyzed a few GEO data sets that were on different microarray platforms using the RankProd R library.

    However, since the data sets were on different microarray platforms, they have different probe sets and hence there were tons of NAs in the all-inclusive expression set. The candidates I ended up taking from this analysis actually ended up working, but I'm wondering if this analysis is defensible.

    Thank you in advance for any insight
  • IonTom
    Member
    • Apr 2014
    • 32

    #2
    From my experience Rank Product test gives much better and reliable results than most parametric methods.

    To your question. You should limit both microarrays to the probes that are available on both platforms. Otherwise the number of probes will be different for both platforms and the ranks will not be comparable.

    But limiting the probe sets should help. If the probes are nor directly matchable,
    you could use the gene level expression for a comparison.

    Comment

    • Randy912
      Junior Member
      • Aug 2016
      • 2

      #3
      The microarray platforms have totally different probe annotations, so there are actually 0 probe sets shared across all platforms.

      When you say "use gene level expression," how do you change the probe set names to facilitate the matches? For example, let's say gene X has probes 38548_at in an affy array, and 294838 in an Illumina array, how do you modify them so that the comparison can be made?

      Thank you for your help.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...